Seol HJ and colleagues confirmed that gliomas exhibit elevated CD99 expression compared to non-neoplastic brain tissue and that silencing CD99 in glioma cells reduces migration and invasiveness without affecting cell viability or proliferation [15]. This evidence concerns the gene CD99 and central nervous system cancer.